rs397515415
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_018486.3(HDAC8):c.490C>T(p.Arg164*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 22)
Consequence
HDAC8
NM_018486.3 stop_gained
NM_018486.3 stop_gained
Scores
2
2
1
Clinical Significance
Conservation
PhyloP100: 3.79
Genes affected
HDAC8 (HGNC:13315): (histone deacetylase 8) Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene belongs to class I of the histone deacetylase family. It catalyzes the deacetylation of lysine residues in the histone N-terminal tails and represses transcription in large multiprotein complexes with transcriptional co-repressors. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-72495216-G-A is Pathogenic according to our data. Variant chrX-72495216-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 39710.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-72495216-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HDAC8 | NM_018486.3 | c.490C>T | p.Arg164* | stop_gained | 5/11 | ENST00000373573.9 | NP_060956.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HDAC8 | ENST00000373573.9 | c.490C>T | p.Arg164* | stop_gained | 5/11 | 1 | NM_018486.3 | ENSP00000362674.3 | ||
ENSG00000285547 | ENST00000648922.1 | c.490C>T | p.Arg164* | stop_gained | 5/12 | ENSP00000497072.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 genomes
Cov.:
22
GnomAD4 exome Cov.: 28
GnomAD4 exome
Cov.:
28
GnomAD4 genome Cov.: 22
GnomAD4 genome
Cov.:
22
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Cornelia de Lange syndrome 5 Pathogenic:4
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 13, 2012 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego | May 08, 2019 | This nonsense variant found in exon 5 of 11 is predicted to result in loss of normal protein function. This variant has been previously reported as a de novo change in patients with Cornelia de Lange syndrome (PMID: 22885700). It is absent from the ExAC and gnomAD population databases and thus is presumed to be rare. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.490C>T (p.Arg164Ter) variant is classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 19, 2014 | This variant has been previously reported as disease-causing and was found once in our laboratory de novo in a 21-year-old female with autism, intellectual disability, hypotonia, hyperextensibility, cardiomyopathy, scoliosis, dysautonomia - |
Pathogenic, criteria provided, single submitter | research | HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology | Nov 10, 2016 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 09, 2017 | The R164X variant in the HDAC8 gene has been reported previously as heterozygous de novo in a female with Cornelia de Lange syndrome who exhibited growth delays, absent speech, dysmorphic facial features, asymmetric skull, limb length discrepancy and dysplastic kidneys (Deardorff et al., 2012). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The R164X variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret R164X as a pathogenic variant. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
FATHMM_MKL
Uncertain
D
Vest4
0.94, 0.93, 0.94, 0.94, 0.94
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at